Sdi Share Discussion Threads

[rivaldo] 21/7/2020 07:53

Maybe so spooky, you could well be right on re-reading - slightly ambiguous methinks given the mention of growth. Nevertheless, things appear to be as rosy all round as one could hope for in the current environment.

[spooky] 21/7/2020 07:35

We read that line differently rivaldo. IMO they sre stating that current year profits are likely to be at least in line with FY20, that is completely different to suggesting they will grow by at least 44%.

[rivaldo] 21/7/2020 07:30

Excellent indeed. The £4.3m adjusted PBT is ahead of expectations of £4.2m, and £24.5m revenues are a good £0.5m above forecasts.

The outlook looks good too, particularly this comment which suggests another 44% rise in adjusted PBT this year:

"For the financial year ending 30 April 2021 the Group expects to report year on year revenue growth and profits at least in line with FY20."

There's some lovely understated commentary along with nuggets of gold. You'd think that the COVID-19 business seems to simply balance the downturn in certain divisions, until you read that:

"Atik, which has worked with this OEM supplier for three years, has increased camera production for them by approximately 10-fold. Atik forecasts it will continue to supply at this increased rate for the next 6-9 months, enabling Atik production to continue at full pace."

And:

"MPB has worked with Penlon for 25 years and has increased its supply rate 20-fold to meet critical delivery timescales."

With SDI's non-COVID related business returning to normality, SDI could benefit from the double whammy of business as usual as well as COVID-19 related business AND new customers and sales resulting from the pandemic and increased awareness of SDI.

[steeplejack] 21/7/2020 07:12

Those are excellent figures.

[ayl30] 21/7/2020 07:12

Steady as she goes, further progress with results today

[cheshire man] 20/7/2020 10:26

Results tomorrow let's hope it has a positive effect on that chart :-)

[rivaldo] 09/7/2020 08:59

Results confirmed for Tuesday 21st July:



We already know that the results to 30th April will be nicely in line with expectations. Hopefully the outlook will reflect continued COVID-19 related sales in the majority of the production units, along with a return to normality for the rest of the business, which should be enough for the share price to resume its long-term advance.

[arregius] 16/6/2020 20:51

https://www.aerospacetestinginternational.com/features/qa-nick-broadley-managing-director-of-chell-instruments.html

[trident5] 10/6/2020 12:31

tjbird - any thoughts? Or any more fair warnings?

[ramridge] 10/6/2020 12:12

It can also spike down to 55 in a flash!

[arab3] 10/6/2020 08:42

You did tell us BWNG looked bust in April !!!

[tjbird] 10/6/2020 08:35

this baby can spike to 68p in five seconds. dont say you werent told. fair warning.

[tjbird] 10/6/2020 08:16

Full price being paid now

[tjbird] 10/6/2020 08:10

First buy of day. Blue day>

[hastings] 10/6/2020 07:40

Good to the share price moving back in the right direction with some decent buys.
Next update results late July and wouldn’t expect another acquisition before then.

[onjohn] 10/6/2020 07:28

Seriously seriously undervalued

[petewy] 09/6/2020 22:11

SEE: hxxps://www.finncap.com/news-events/finncap-research-company-notes-6-february-2020

[gdjs100] 09/6/2020 22:00

That research was published on 6 Feb.

[johndoe23] 09/6/2020 19:41

Thanks for that post. Their price target of 105p is not too dissimilar to mine. With 3.6p EPS forecast for FY21, the shares are on a forward pe of just 16.

[tjbird] 09/6/2020 15:31

SDI Group (SDI) : Corp

Life Sciences

Running the Slide Rule over SDI
SDI was selected in finnCap’s Slide Rule QVGM+ top 30 stocks in Q1 2020, reflecting the projected strong sales and EPS growth over the next two financial years of 30% and 31% respectively, buoyed by recent acquisitions but more importantly the rising ROCE. The prospect of sustainable organic growth is considered likely for this buy-and-build model given ongoing investment to support portfolio companies’ ambitions. These quality metrics are also seen in Judges Scientific (a larger buy-and build investment story), which despite three-year 9% EPS CAGR, trades on a FY 2020 P/E of c.25x and FCF yield of 4.2%. Given the successful acquisition and integration of 11 businesses over the past six years, and mindful of opportunities that still exist for SDI, we are raising our target price to 105p

[tjbird] 09/6/2020 15:27

Wont surprise to see an RNS with an earnings enhancing acquition tomorrow after that 50k buy. Very confident i agree....:)

[cheshire man] 09/6/2020 14:43

50,000 @60.4p that's a confident buy :-)